Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation.

Summary

The purpose of the study is to assess the efficacy of flecainide controlled release (CR) in the prevention of recurrent AF during 9 months of active treatment compared to placebo in patients with only one documented AF episode.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications